MedKoo Cat#: 527072 | Name: 4-Amino-PPHT Hydrobromide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

4-Amino-PPHT Hydrobromide is a precursor for fluorescent labeled Dopamine D2 receptors (D2R) agonist.

Chemical Structure

4-Amino-PPHT Hydrobromide
4-Amino-PPHT Hydrobromide
CAS#129298-03-9

Theoretical Analysis

MedKoo Cat#: 527072

Name: 4-Amino-PPHT Hydrobromide

CAS#: 129298-03-9

Chemical Formula: C21H29BrN2O

Exact Mass: 404.1463

Molecular Weight: 405.38

Elemental Analysis: C, 62.22; H, 7.21; Br, 19.71; N, 6.91; O, 3.95

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
4-Amino-PPHT Hydrobromide
IUPAC/Chemical Name
6-[[2-(4-Aminophenyl)ethyl]propylamino]-5,6,7,8-tetrahydro-1-naphthalenol hydrobromide
InChi Key
JLEJPNRRWHBLOH-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H28N2O.BrH/c1-2-13-23(14-12-16-6-8-18(22)9-7-16)19-10-11-20-17(15-19)4-3-5-21(20)24;/h3-9,19,24H,2,10-15,22H2,1H3;1H
SMILES Code
OC1=C2CCC(N(CCC3=CC=C(N)C=C3)CCC)CC2=CC=C1.[H]Br
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 405.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Szeto J, Lemoine R, Nguyen R, Olson LL, Tanga MJ. Synthesis of [(15) N]-Cholamine Bromide Hydrobromide. J Labelled Comp Radiopharm. 2017 Dec 26. doi: 10.1002/jlcr.3598. [Epub ahead of print] PubMed PMID: 29278650. 2: Umino M, Umino A, Nishikawa T. Effects of selective calcium-permeable AMPA receptor blockade by IEM 1460 on psychotomimetic-induced hyperactivity in the mouse. J Neural Transm (Vienna). 2017 Dec 21. doi: 10.1007/s00702-017-1827-3. [Epub ahead of print] PubMed PMID: 29270730. 3: Omar MA, Badr El-Din KM, Salem H, Abdelmageed OH. Novel kinetic spectrophotometric method for estimation of certain biologically active phenolic sympathomimetic drugs in their bulk powders and different pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc. 2017 Dec 14;193:310-317. doi: 10.1016/j.saa.2017.12.045. [Epub ahead of print] PubMed PMID: 29258026. 4: Lu C, Dong L, Lv J, Wang Y, Fan B, Wang F, Liu X. 20(S)-protopanaxadiol (PPD) alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of Egr-1, c-Fos and c-Jun in mice. Chem Biol Interact. 2018 Jan 5;279:64-72. doi: 10.1016/j.cbi.2017.11.008. Epub 2017 Nov 10. PubMed PMID: 29133030. 5: Bao L, Sha XY, Zhao H, Han SQ, Hasi WL. Detection of Scopolamine Hydrobromide via Surface-enhanced Raman Spectroscopy. Anal Sci. 2017;33(11):1237-1240. doi: 10.2116/analsci.33.1237. PubMed PMID: 29129861. 6: Omar MA, Badr El-Din KM, Salem H, Abdelmageed OH. Spectrophotometric and spectrofluorimetric methods for determination of certain biologically active phenolic drugs in their bulk powders and different pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc. 2017 Nov 8;192:108-116. doi: 10.1016/j.saa.2017.10.065. [Epub ahead of print] PubMed PMID: 29127827. 7: Chen D, Xie X, Chen Q, Liu H, Zhang S, Wan F, Ao H, Peng C. Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats. CNS Neurol Disord Drug Targets. 2017 Oct 26. doi: 10.2174/1871527316666171026114043. [Epub ahead of print] PubMed PMID: 29076436. 8: Parker PD, Lemercier BC, Pierce JG. Synthesis of Quaternary-Substituted Thiazolines via Halocyclization of S-Allyl Thioimidate Salts. J Org Chem. 2017 Oct 24. doi: 10.1021/acs.joc.7b02299. [Epub ahead of print] PubMed PMID: 29064693. 9: Wlodek M, Kolasinska-Sojka M, Wasilewska M, Bikondoa O, Briscoe WH, Warszynski P. Interfacial and structural characteristics of polyelectrolyte multilayers used as cushions for supported lipid bilayers. Soft Matter. 2017 Nov 8;13(43):7848-7855. doi: 10.1039/c7sm01645j. PubMed PMID: 28976532. 10: Cirlini M, Demuth TM, Biancardi A, Rychlik M, Dall'Asta C, Bruni R. Are tropane alkaloids present in organic foods? Detection of scopolamine and atropine in organic buckwheat (Fagopyron esculentum L.) products by UHPLC-MS/MS. Food Chem. 2018 Jan 15;239:141-147. doi: 10.1016/j.foodchem.2017.06.028. Epub 2017 Jun 23. PubMed PMID: 28873551. 11: Ponzoni L, Braida D, Bondiolotti G, Sala M. The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish. Front Psychiatry. 2017 Aug 14;8:146. doi: 10.3389/fpsyt.2017.00146. eCollection 2017. PubMed PMID: 28855876; PubMed Central PMCID: PMC5557732. 12: Lin Q, Jia Z, Xu X, Xu S, Han T, Gao Y, Zhang Y, Zhang H, Liu H, Li J, Li X. Sub-chronic toxicity study of arecae semen aqueous extract in Wistar rats. J Ethnopharmacol. 2017 Aug 25. pii: S0378-8741(16)32236-X. doi: 10.1016/j.jep.2017.08.031. [Epub ahead of print] PubMed PMID: 28847753. 13: Sánchez-Brualla I, Boulenguez P, Brocard C, Liabeuf S, Viallat-Lieutaud A, Navarro X, Udina E, Brocard F. Activation of 5-HT(2A) receptors restores KCC2 function and reduces neuropathic pain after spinal cord injury. Neuroscience. 2017 Aug 30. pii: S0306-4522(17)30599-7. doi: 10.1016/j.neuroscience.2017.08.033. [Epub ahead of print] PubMed PMID: 28844001. 14: Koga M, Kanaoka Y, Sugiyama K, Ohishi K, Ejima Y, Hisanaga M, Kataoka Y, Yamauchi A. Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis. Toxicology. 2017 Sep 1;390:1-9. doi: 10.1016/j.tox.2017.08.006. Epub 2017 Aug 24. PubMed PMID: 28842382. 15: McMillan DM, Tyndale RF. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response. Biochem Pharmacol. 2017 Dec 1;145:158-168. doi: 10.1016/j.bcp.2017.08.015. Epub 2017 Aug 21. PubMed PMID: 28837793. 16: Arafa NMS, Ali EHA, Hassan MK. Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action. Chem Biol Interact. 2017 Nov 1;277:195-203. doi: 10.1016/j.cbi.2017.08.013. Epub 2017 Aug 22. PubMed PMID: 28837785. 17: Casalia ML, Howard MA, Baraban SC. Persistent seizure control in epileptic mice transplanted with gamma-aminobutyric acid progenitors. Ann Neurol. 2017 Oct;82(4):530-542. doi: 10.1002/ana.25021. Epub 2017 Oct 4. PubMed PMID: 28833459. 18: Kim HB, Lee S, Hwang ES, Maeng S, Park JH. p-Coumaric acid enhances long-term potentiation and recovers scopolamine-induced learning and memory impairments. Biochem Biophys Res Commun. 2017 Oct 21;492(3):493-499. doi: 10.1016/j.bbrc.2017.08.068. Epub 2017 Aug 19. PubMed PMID: 28830814. 19: Allen C, Zarowitz B, O'Shea T, Peterson E, Yonan C, Waterman F. Identification of pseudobulbar affect symptoms in the nursing home setting: Development and assessment of a screening tool. Geriatr Nurs. 2017 Aug 11. pii: S0197-4572(17)30155-6. doi: 10.1016/j.gerinurse.2017.06.002. [Epub ahead of print] PubMed PMID: 28807457. 20: Leon MI, Rodriguez-Barrera V, Amaya A. The effect of scopolamine on matching behavior and the estimation of relative reward magnitude. Behav Neurosci. 2017 Oct;131(5):406-20. doi: 10.1037/bne0000213. Epub 2017 Aug 14. PubMed PMID: 28805429.